N/A
N=94
Post-market, Prospective Evaluation of PHOTO-oxidized Bovine Pericardium in Vascular Surgery
Vascular Diseases · Peripheral Arterial Disease · Hemodialysis Access Failure (Disorder) · Carotid Artery Diseases · Abdominal Aortic Aneurism
Bottom Line
View on ClinicalTrials.gov: NCT03669042 ↗Enrolled (actual)
94
Serious AEs
12.8%
Results posted
Oct 2024
Primary outcome: Primary: Incidence of Central Neurologic Events — 2 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- PhotoFix (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Artivion Inc.
- Primary completion
- Jul 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Incidence of Central Neurologic Events |
2 | — |
| PRIMARY Primary Patency |
16 | — |
| SECONDARY Overall Survival |
94 | — |
| SECONDARY All-Cause Re-operation Rate |
1 | — |
| SECONDARY Device-Related Re-operation Rate |
— | — |
| SECONDARY Explant Rate |
— | — |
| SECONDARY Adverse Event Rate |
28 | — |
| SECONDARY Restenosis Rate |
4 | — |
| SECONDARY Secondary Patency |
— | — |
Summary
The objective of this post-market clinical follow-up study is to evaluate the clinical outcomes of patients receiving PhotoFix as a patch within a vascular repair or reconstruction procedure.
Eligibility Criteria
Inclusion Criteria
- Patient is undergoing a vascular procedure which falls within the indications for use and requires the use of PhotoFix Decellularized Bovine Pericardium
- Patient's surgery is anticipated to occur within 60 days of consent
- Patient is ≥18 years old
- Patient is willing and able to comply with the protocol and follow up period
- Patient is willing and able to give written informed consent
Exclusion Criteria
- Patient's procedure is a revision of a prior arteriotomy or venotomy
- Patient's procedure requires multiple vascular patches in anatomically distinct regions or other prosthetics (e.g. stents)
- Patient has a medical history of abnormal coagulopathy, bleeding, or thromboembolic disease
- Patient has a medical history of severe immunodeficiency disease
- Patient has a medical history of cancer
- Patient has severe visceral disease in heart or active liver disease or icterus
- Patient has a history of cerebrovascular accident (completed stroke) within 3 months of planned surgery
- Patient has a history of atrial fibrillation and requires a patch for carotid endarterectomy repair
- Patient has an active or potential infection at the surgical site
- Patient has used or plans to use immunomodulatory drugs for ≥ 6 months
- Patient has a sensitivity to products of bovine origin
- Patient is currently enrolled in another study
- Patient has a life expectancy of less than 12 months
- Patient is pregnant or breastfeeding or planning on becoming pregnant or unwilling to use medically acceptable methods of birth control
- Patient's procedure is emergent
Data sourced from ClinicalTrials.gov (NCT03669042). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.